Parallel Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Sell
3,608
-35
-1% -$985 ﹤0.01% 1704
2026
Q1
$104K Sell
3,643
-416
-10% -$14.2K ﹤0.01% 1562
2025
Q4
$161K Sell
4,059
-2,877
-41% -$105K ﹤0.01% 1198
2025
Q3
$244K Sell
6,936
-293
-4% -$10.1K ﹤0.01% 958
2025
Q2
$237K Hold
7,229
﹤0.01% 937
2025
Q1
$233K Buy
7,229
+833
+13% +$30.9K 0.01% 894
2024
Q4
$195K Hold
6,396
﹤0.01% 944
2024
Q3
$179K Sell
6,396
-1,129
-15% -$27.8K ﹤0.01% 977
2024
Q2
$171K Buy
7,525
+1,824
+32% +$42.1K ﹤0.01% 927
2024
Q1
$173K Buy
5,701
+29
+0.5% +$971 ﹤0.01% 911
2023
Q4
$202K Sell
5,672
-38
-0.7% -$1.41K 0.01% 797
2023
Q3
$250K Sell
5,710
-37
-0.6% -$1.8K 0.01% 692
2023
Q2
$284K Buy
5,747
+15
+0.3% +$691 0.01% 635
2023
Q1
$238K Buy
5,732
+894
+18% +$37.1K 0.01% 697
2022
Q4
$215K Buy
4,838
+149
+3% +$6.22K 0.01% 668
2022
Q3
$183K Buy
4,689
+393
+9% +$18K 0.01% 714
2022
Q2
$176K Buy
4,296
+52
+1% +$2.46K 0.01% 734
2022
Q1
$273K Sell
4,244
-73
-2% -$4.73K 0.01% 611
2021
Q4
$300K Buy
4,317
+323
+8% +$23.5K 0.01% 602
2021
Q3
$278K Buy
3,994
+11
+0.3% +$846 0.01% 596
2021
Q2
$316K Hold
3,983
0.01% 518
2021
Q1
$261K Buy
3,983
+2,979
+297% +$183K 0.01% 548
2020
Q4
$56K Hold
1,004
﹤0.01% 1050
2020
Q3
$40K Hold
1,004
﹤0.01% 1148
2020
Q2
$45K Buy
1,004
+4
+0.4% +$174 ﹤0.01% 1081
2020
Q1
$33K Hold
1,000
﹤0.01% 1094
2019
Q4
$33K Hold
1,000
﹤0.01% 1180
2019
Q3
$25K Buy
+1,000
New +$28.6K ﹤0.01% 1252

Other funds holding ATRC

Parallel Advisors's ATRC Position: Q2 2026 in Review

Parallel Advisors reduced its AtriCure (ATRC) stake by 0.96% in Q2 2026, selling an estimated $985 and leaving 3,608 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

Parallel Advisors first reported a position in ATRC in Q3 2019 and has held it in 28 quarters since. The position peaked at $316K in Q2 2021. 78 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Parallel Advisors held 3,608 shares of AtriCure worth $101K as of Q2 2026.
  • Parallel Advisors sold 35 AtriCure shares in Q2 2026, an estimated $985.
  • AtriCure made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1704 holding.
  • Parallel Advisors first reported a position in AtriCure in Q3 2019 and has held it in 28 quarters since.
  • Parallel Advisors's AtriCure position peaked at $316K in Q2 2021.
  • 78 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.